Particularly, it provides evidence that CKD-associated cardiac hypertrophy correlates with reduced eGFR and soluble Klotho and Vitamin D levels, and is indicative of a generalized pro-inflammatory status, as evidenced by increased levels of IL-6, ACR, PTH, P and FGF23. This evidence concerns the gene FGF23 and cardiac hypertrophy.